Antiviral Drugs
OwnerCameron Stewart, Andrew Beaninventors
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to methods of treating or preventing a viral infection in a subject. More specifically, the invention relates to methods of treating or preventing a Mononegavirales viral infection in a subject that comprises administering an effective amount of an angiotensin II signalling inhibitor.
Claims22
A method of treating or preventing a Mononegavirales viral infection in a subject, the method comprising administering an effective amount of an angiotensin II signalling inhibitor.
An angiotensin II signalling inhibitor when used in a method for treating or preventing a Mononegavirales viral infection in a subject.
Use of an angiotensin II signalling inhibitor in the manufacture of a medicament for the treatment or prevention of a Mononegavirales viral infection in a subject.
Dependencies are inferred from the claim text.